[Verified Answer]: You are reassessing your patient’s asthma plan

You are reassessing your patient’s asthma plan. The patient takes an inhaled short-acting beta2 agonist (SABA) as needed. He reports daytime symptoms not daily, but more than 3 days/week, and nighttime symptoms 4 to 5 times/week. FEV1 is 80% of predicted. What treatment would be indicated to help control this patient’s symptoms? Budesonide with montelukast Fluticasone or Salmeterol Budesonide with formoterol Cromolyn or nedrocromil